Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Fatty Acid Oxidation Defects in Insulin Sensitivity

NCT02517307 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02517307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02517307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
March 31, 2021
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carnitine palmitoyltransferase ii deficiency, myopathic, long-chain 3-hydroxyacyl-coa dehydrogenase deficiency, medium-chain acyl-coa dehydrogenase deficiency, normal volunteers, trifunctional protein deficiency, very long-chain acyl-coa dehydrogenase deficiency